Congenital heart defects (CHDs) encompass structural abnormalities that manifest at birth, exerting an impact on both the form and function of the heart. These defects arise during fetal development when the heart is forming, and they can involve the heart valves, walls, arteries, or veins. CHDs vary widely in severity, with some causing minor issues and others posing life-threatening challenges. While the exact cause of most congenital heart defects remains unknown, certain factors such as genetic predisposition, maternal health, and environmental influences may contribute. The symptoms and consequences of CHDs can manifest at different stages of life, necessitating early detection and intervention. Advances in medical technology and surgical techniques have significantly improved the prognosis for individuals with congenital heart defects, allowing many to lead fulfilling and relatively normal lives with appropriate medical care and support. However, ongoing research and awareness efforts are crucial to further understand and address the complexities of congenital heart defects, ultimately improving outcomes and quality of life for those affected.
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain